Terumo (OTCMKTS:TRUMY) Stock Price Down 5.3% – What’s Next?

Terumo Corp. (OTCMKTS:TRUMY) shares fell 5.3% during trading on Friday . The stock traded as low as $13.90 and last traded at $13.90. Approximately 5,372 shares traded hands during trading, a decline of 98% from the average daily volume of 251,850 shares. The stock had previously closed at $14.68.

Wall Street Analyst Weigh In

Separately, Nomura raised Terumo from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 30th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, Terumo presently has an average rating of “Buy”.

Terumo Trading Down 3.7%

The company has a quick ratio of 1.37, a current ratio of 2.19 and a debt-to-equity ratio of 0.13. The business’s fifty day moving average price is $14.98 and its 200 day moving average price is $14.04. The firm has a market capitalization of $20.85 billion, a PE ratio of 19.91 and a beta of 0.68.

Terumo (OTCMKTS:TRUMY) last announced its quarterly earnings results on Friday, August 7th. The company reported $0.30 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.13. The company had revenue of $1.97 billion for the quarter, compared to analyst estimates of $1.84 billion. Terumo had a net margin of 13.83% and a return on equity of 10.44%. As a group, analysts expect that Terumo Corp. will post 0.7 EPS for the current fiscal year.

About Terumo

Terumo Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other health care settings. Founded in 1921, the company has grown from producing clinical thermometers into a global provider of medical devices and related solutions.

Terumo’s businesses include cardiovascular and vascular intervention products, such as catheters, guidewires and other devices used in the treatment of heart and vascular conditions.